Clinical Trial Update: Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating Z-360 in combination with gemcitabine for unresectable advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Z-360

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED